Weninger B, Czerner S, Steude U, Weninger E
Klinik für Anästhesiologie und Intensivmedizin der Ludwig-Maximilians-Universität München, Munich.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2004 Apr;39(4):212-9. doi: 10.1055/s-2004-814363.
Total intravenous anaesthesia (TIVA) is increasingly used in diagnostic surgery such as stereotactic biopsy of the brain. TIVA could lead to a faster recovery of cerebral function, which may lead to a better behavior and advantages in the postoperative management. The aim of this prospective, single-blind study was to compare the hemodynamics, the postoperative recovery period, the side-effects and the need for additional cardiovascular medication during and after the operation between the three study groups.
After giving informed consent and approval by the ethical committee of our hospital, 51 patients (ASA I and II) undergoing stereotactic biopsy of a brain tumor were randomized to receive either propofol via the TCI-system (group 1: TCI-TIVA), propofol by a manual technique (group 2: MAN-TIVA) or methohexitone-sevoflurane (group 3: BAL-SEVO). Remifentanil was used as the analgetic component in all groups. Systolic and diastolic blood pressure, heart rate und transcutaneous oxygen saturation were noted before and after induction and before and after the end of anaesthesia. The time until return of complete orientation relative to person, location and time were measured. The patients' ranking of their satisfaction with the anaesthesia was questioned 60 min and 24 hours after the end of the procedure (VAS). Undesirable side-effects (i. e. PONV, shivering, pain, dysphoria, tiredness) were noted, whenever they occurred. The number of hemodynamic interventions by the anaesthesiologist was counted, and the total doses of remifentanil and propofol were quoted. Depth of anaesthesia was monitored by using a BIS-system, a range between 40 and 50 was thought to be adequate. Besides this, the total doses of remifentanil, propofol and sevoflurane were ruled out and the costs of the three regimens were ranked.
Heart rate dropped markedly in all groups with a maximum in the TIVA-collective. Systolic and diastolic pressure also fell in the groups. In the SEVO-group, the difference was statistically significant only at the end of anaesthesia. After extubation, the three groups reached their hemodynamic starting-point with a slight overshoot in the SEVO-group. The number of required hemodynamic interventions was two (TCI-TIVA) vs. 7 (MAN-TIVA) vs. 8 (BAL-SEVO) in each group, respectively. The difference scarcely failed to get significance. The remifentanil requirements were similar between the collectives, group 1 needed more propofol per time than group 2. The number of side-effects was very little after the different regimens. There were no differences with regard to the other measured parameters between the groups. The use of TCI-TIVA was more expensive than manual TIVA (18,85 euro vs. 12,50 euro). Surprisingly, balanced anaesthesia using Sevoflurane was the most expensive method during the first hour, mainly due to the use of methohexitone as the induction agent (23,90 euro).
Each of the three techniques compared in our study is suitable for anaesthesia in diagnostic neurosurgery. Since fast recovery of vigilance is important to justify the neurological outcome, none of the methods seems to be superior to the others. The hemodynamics were largely stable with a strong trend towards minor necessity for hemodynamic intervention in the TCI-TIVA group. This is also the best method from the subjective point of view of the anaesthesiologist due to the easy handling and the low number of interventions. The use of newer TCI-systems (e. g. fm-controller, Braun, Melsungen) not operating with special application syringes will cheapen TCI-TIVA.
全静脉麻醉(TIVA)越来越多地用于诊断性手术,如脑立体定向活检。TIVA可使脑功能恢复更快,这可能导致更好的行为表现以及术后管理方面的优势。这项前瞻性单盲研究的目的是比较三个研究组在手术期间及术后的血流动力学、术后恢复期、副作用以及额外心血管药物的使用需求。
在获得患者知情同意并经我院伦理委员会批准后,51例(ASA I级和II级)接受脑肿瘤立体定向活检的患者被随机分为三组,分别通过靶控输注系统接受丙泊酚(第1组:TCI-TIVA)、采用手动技术给予丙泊酚(第2组:MAN-TIVA)或美索比妥-七氟烷(第3组:BAL-SEVO)。所有组均使用瑞芬太尼作为镇痛成分。记录诱导前后、麻醉结束前后的收缩压、舒张压、心率及经皮血氧饱和度。测量完全恢复定向(相对于人物、地点和时间)所需的时间。在手术结束后60分钟和24小时询问患者对麻醉的满意度评分(视觉模拟评分法)。记录任何时候出现的不良副作用(即恶心呕吐、寒战、疼痛、烦躁、疲劳)。统计麻醉医生进行血流动力学干预的次数,并列出瑞芬太尼和丙泊酚的总剂量。使用脑电双频指数(BIS)系统监测麻醉深度,40至50的范围被认为是合适的。此外,排除瑞芬太尼、丙泊酚和七氟烷的总剂量,并对三种方案的费用进行排序。
所有组的心率均显著下降,TIVA组下降幅度最大。收缩压和舒张压在各组中也有所下降。在七氟烷组,仅在麻醉结束时差异有统计学意义。拔管后,三组均恢复至血流动力学起始点,七氟烷组有轻微超调。每组所需的血流动力学干预次数分别为2次(TCI-TIVA)、7次(MAN-TIVA)和8次(BAL-SEVO)。差异几乎无统计学意义。各组间瑞芬太尼需求量相似,第1组每次所需丙泊酚比第2组多。不同方案后的副作用数量很少。各组间在其他测量参数方面无差异。使用TCI-TIVA比手动TIVA更昂贵(18.85欧元对12.50欧元)。令人惊讶的是,使用七氟烷的平衡麻醉在第一小时是最昂贵的方法,主要是因为使用美索比妥作为诱导剂(23.90欧元)。
我们研究中比较的三种技术中的每一种都适用于诊断性神经外科手术的麻醉。由于快速恢复清醒对判断神经功能结果很重要,似乎没有一种方法优于其他方法。血流动力学在很大程度上是稳定的,TCI-TIVA组在血流动力学干预必要性方面有明显的较小趋势。从麻醉医生的主观角度来看,这也是最好的方法,因为操作简便且干预次数少。使用不与特殊应用注射器配合使用的新型TCI系统(如fm控制器,贝朗,梅尔松根)将降低TCI-TIVA的成本。